Consolidated Statements of Shareholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Ordinary Shares	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Apr. 30, 2022		144,755
Beginning balance at Apr. 30, 2022	$ 334,163	$ 7	$ 424,562	$ 23	$ (90,429)
Ordinary shares issued under employee share incentive plan (in shares)		3,896
Ordinary shares issued under employee share incentive plans	5,497		5,497
Share-based compensation	23,516		23,516
Warrant contra revenue	1,220		1,220
Total comprehensive loss	(16,761)			(214)	(16,547)
Ending balance (in shares) at Apr. 29, 2023		148,651
Ending balance at Apr. 29, 2023	347,635	$ 7	454,795	(191)	(106,976)
Issuance of common stock in connection with secondary public offering, net of offering costs (in shares)		10,440
Issuance of common stock in connection with secondary public offering, net of offering costs	173,416	$ 1	173,415
Ordinary shares issued under employee share incentive plan (in shares)		5,329
Ordinary shares issued under employee share incentive plans	7,055		7,055
Tax withheld related to RSU settlement (shares)		(115)
Tax withheld related to RSU settlement	(2,158)		(2,158)
Share-based compensation	39,022		39,022
Warrant contra revenue	3,925		3,925
Total comprehensive loss	$ (28,697)			(328)	(28,369)
Ending balance (in shares) at Apr. 27, 2024	164,305	164,305
Ending balance at Apr. 27, 2024	$ 540,198	$ 8	676,054	(519)	(135,345)
Ordinary shares issued under employee share incentive plan (in shares)		7,057
Ordinary shares issued under employee share incentive plans	7,831		7,831
Tax withheld related to RSU settlement (shares)		(194)
Tax withheld related to RSU settlement	(9,253)		(9,253)
Share-based compensation	77,355		77,355
Warrant contra revenue	13,186		13,186
Total comprehensive loss	$ 52,265			82	52,183
Ending balance (in shares) at May. 03, 2025	171,169	171,169
Ending balance at May. 03, 2025	$ 681,582	$ 8	$ 765,173	$ (437)	$ (83,162)